Evidence map›Paper›PMID 19356618›Full record

ArticleVaccine2009

Contribution of IRF-3 mediated IFNbeta production to DNA vaccine dependent cellular immune responses.

Hidekazu Shirota, Lev Petrenko, Toshio Hattori, Dennis M Klinman

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. DNA vaccines for prostate cancer.Pharmacology & therapeutics · 2017
    Review
  2. Article
  3. DNA vaccines: a simple DNA sensing matter?Human vaccines & immunotherapeutics · 2013
    Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Hidekazu ShirotaLaboratory of Experimental Immunology, National Cancer Institute, Frederick, MD, 21702, United States.
Lev Petrenko
Toshio Hattori
Dennis M Klinman
National Cancer Institute · USTohoku University · JP

Funding

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotidesZIABC010852 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLINMAN, DENNIS · 2009 to 2019
$11.3M
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleoZ01BC010852 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLINMAN, DENNIS · 2007 to 2008
$1.9M
Intramural NIH HHS Z01 BC010852
6 · The paper itself

Abstract

The mechanism(s) by which DNA vaccines activate Ag-specific cellular immune responses is incompletely understood. Current findings indicate that IRF-3 plays an important role in this process. The IRF-3 dependent signaling pathway is triggered by the presence of intracytoplasmic DNA, and culminates in the production of type I IFNs. DNA vaccination of IRF-3 KO mice elicits a strong Ag-specific humoral response, yet CD4 and CD8 T cell responses (including the production of Th1, Th2 and Th 17 cytokines) are severely impaired. Although expression of the immunogenic protein encoded by the DNA vaccine was similar in IRF-3 KO vs wild type mice, antigen presentation was severely impaired in the KO animals. This defect was remedied by the co-delivery of an IFNbeta encoding plasmid. These findings suggest that the IRF-3/IFNbeta pathways are key to the induction of cellular immunity following DNA vaccination.

Indexed as

Adoptive TransferAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCells, CulturedImmunity, CellularInterferon-betaInterferon Regulatory Factor-3MiceMice, Inbred C57BLMice, KnockoutPlasmidsSpleenVaccines, DNAInterferon-betaInterferon Regulatory Factor-3Irf3 protein, mouseVaccines, DNA

Identifiers

PMID19356618
PMCPMC2667800
OpenAlexW2030109246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.